Ruili Medical Aesthetic (02135) subsidiary plans to subscribe for 51.0% of Riley Medical Beauty's shares for HK$2.55 million

Zhitong Financial App News, Ruili Medical & Aesthetic (02135) announced that on January 6, 2026, Miu Shi Aesthetics, investors (the company's indirect non-wholly-owned subsidiaries Ruili Aesthetics Co., Ltd., Biff Co., Ltd.), shareholders (the company's indirect wholly-owned subsidiary Ruili Medical Limited, Hong Kong Fanxi Information Service Co., Ltd.) and the target company Laili Medical & Aesthetic Co., Ltd. agreed to issue a total of 170,000 shares to the first investor Ruili Aesthetics Co., Ltd., with a subscription price of HK$2.55 million; and Miao Shi Aesthetics and Target Agree to the second Investor Biff Limited issued a total of 63,300 shares at a subscription price of HK$950,000, subject to the terms and conditions set out in the subscription agreement. After completion, Miu Shi Aesthetics, the first investor, and the second investor will hold 30.0%, 51.0% and 19.0% of the target company's shares respectively. The target company will be an indirect non-wholly-owned subsidiary of the company; and the target company's financial results will be incorporated into the group accounts after completion.

The target company (Laili Medical Aesthetic Co., Ltd. (formerly “Muse Medical Aesthetic Co., Ltd.”) is a limited company established in Hong Kong. The target company has not yet started business operations, and plans to mainly provide beauty services and other related services after completion.

The Board of Directors believes that the subscription matters are in line with the Group's business development strategy. The Group sees the subscription as a unique opportunity to expand the scope of business in Hong Kong and achieve synergy with its existing business by promoting the brand and providing beauty services to potential customers in Hong Kong. The directors believe that the target company's operating and financial performance is expected to improve after starting the beauty business in Hong Kong, which can bring potential return on investment to the Group.